FDA updates reporting requirements for product adverse effects

The U.S. Food and Drug Administration has updated its guidance for reporting adverse effects of various products, including dietary supplements, during the coronavirus pandemic. The FDA does not consider CBD a dietary supplement. But many CBD manufacturers do and follow FDA guidance on making and selling dietary supplements. The agency made the announcement this month, saying […]

FDA updates reporting requirements for product adverse effects is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs